Dr Anne Moore

UK Clinical Vaccine Network Conference 2024
Wednesday 12th - Thursday 13th June 2024

Dr Anne Moore

After completing a PhD in HIV vaccine immunology Dr Anne Moore completed post-doctoral work on defects in immune responses in HIV-infected individuals in the Wistar Institute in Philadelphia and further work on recombinant DNA and adenovirus vaccines against HIV and Ebola viruses in Dr Gary Nabel's lab, at the University of Michigan. As a senior immunologist in Prof. Adrian Hill's group in the University of Oxford, she developed several T cell inducing vaccine candidates against malaria, TB and influenza. She became a lecturer in Pharmacology, at the School of Pharmacy, UCC, in early 2007. In 2016 she worked in the vaccine biotech company, Vaxart, South San Francisco while on sabbatical. Here she worked on oral vaccines for a range of therapeutic and prophylactic vaccines. In September 2018, she took a position as Senior Lecturer in Biochemistry and Cell Biology, UCC.
Her research interests are in vaccine development, access and acceptability. She is interested in developing efficacious vaccines that can be thermostabilised for easy distribution and new, needle-free formats for easy administration. Dr Moore and colleagues in the School of Pharmacy have also published on vaccine confidence in Ireland.

Top